Status:
UNKNOWN
Neochordae Technique in Mitral Valve Repair
Lead Sponsor:
National Heart Institute, Egypt
Conditions:
Mitral Valve Prolapse
Mitral Regurgitation
Eligibility:
All Genders
30-70 years
Phase:
PHASE1
Brief Summary
Mitral valve (MV) repair has turned into a preferable option for surgeons over the MV replacement. Since the 1960s, Surgeons use this technique for more efficiency and durability. On the other hand, t...
Detailed Description
Mitral regurgitation (prolapse) and mitral stenosis are examples of diseases that affect the mitral valve. In mitral regurgitation, the leaflets do not close tightly and sway up and down allowing the ...
Eligibility Criteria
Inclusion
- Prolapsed or ruptured chordae
- Either degenerative or ischemic
Exclusion
- Patient with redo Mitral Valve surgery
- Patient with severe rheumatic mitral stenosis (MS).
Key Trial Info
Start Date :
March 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04299334
Start Date
March 2 2020
End Date
March 1 2022
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yosry Mahmoud Thakeb
El-Sheikh Zayed City, Giza Governorate, Egypt, 12511